What is the current Captopril Tablets market size

The Captopril Tablets market size is approximately USD 1.2 billion as of 2023

What is the growth forecast for the Captopril Tablets market

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033

What are the key drivers of the Captopril Tablets market

Increasing prevalence of hypertension and cardiovascular diseases drive the market

What are the challenges facing the Captopril Tablets market

Stringent regulatory requirements and patent expirations pose significant challenges

Which regions are leading the Captopril Tablets market

North America and Europe are the leading regions due to high healthcare expenditure

Who are the top companies in the Captopril Tablets market

Pfizer, Sanofi, and Bristol Myers Squibb are among the top companies

What future opportunities exist in the Captopril Tablets market

Emerging markets and increasing demand for generic drugs present future opportunities

How does technology impact the Captopril Tablets market

Advances in drug delivery systems and digital health technologies enhance market growth

What is the regulatory landscape for the Captopril Tablets market

Regulatory bodies such as FDA and EMA ensure compliance with strict guidelines

What is the future outlook for the Captopril Tablets market

The market is expected to witness significant growth due to increasing demand

Captopril Tablets Market 2026: Primary Research + Expert Analysis

Captopril Tablets by Application (Hypertension, Acute Congestive Heart Failure, Chronic Congestive Heart Failure), by Types (Specification 25mg, Specification 12.5mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Captopril Tablets Market Size | CAGR 5.2 Forecast 2033

Captopril Tablets Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Captopril Tablets Market Overview

The Captopril Tablets market refers to the global industry involved in the production and distribution of captopril tablets, a type of medication used to treat high blood pressure and heart failure. As the pharmaceutical industry continues to evolve, the Captopril Tablets market size is expected to experience significant growth, driven by an increasing demand for effective and affordable treatments. The growth outlook for the Captopril Tablets market is promising, with a market forecast that indicates a steady expansion over the next few years. The industry expansion is expected to be driven by advancements in technology, changing regulatory landscapes, and shifting consumer behaviors.

Loading chart…

The current Captopril Tablets market size is approximately $1.3 billion, with a growth forecast that indicates a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033. The market is driven by several key forces, including technology shifts towards more efficient manufacturing processes, regulations that promote the use of generic medications, and consumer behavior that prioritizes affordable and effective treatments. The largest region for the Captopril Tablets market is North America, while the fastest-growing region is expected to be Asia-Pacific. Overall, the Captopril Tablets market is poised for significant growth and expansion over the next few years, driven by a combination of macro drivers and industry trends.

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 million
Revenue forecast in 2033	7.20 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Wockhardt; Tecoland; Farmhispania; Azelis Deutschland Pharma; Kerui Pharmaceutical; Humanwell Pharmaceutical; Hengcheng Pharmaceutical; Hengwei Pharmaceutical; Zhongfu Pharmaceutical; Likang Pharmaceutical; Changjiang Pharmaceutical; Baiyunshan Pharmaceutical; Huaxin Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Captopril Tablets market is poised for significant growth, driven by increasing demand for effective hypertension treatments and expanding applications in cardiovascular diseases. Understanding the dynamics of this market is crucial for stakeholders to navigate its complexities and capitalize on emerging opportunities.

Growth Drivers2 items

Rising prevalence of hypertension and heart failure, driving the demand for Captopril Tablets as a first-line treatment option, thereby influencing the Captopril Tablets market size.

Advancements in drug delivery technologies, enhancing the efficacy and patient compliance of Captopril Tablets, which is expected to contribute to the growth forecast of the market.

Restraints2 items

Stringent regulatory requirements and intense competition from generic versions of Captopril Tablets, potentially limiting the market growth and impacting the Captopril Tablets market size.

Side effects associated with long-term use of Captopril Tablets, such as cough and renal impairment, which may hinder patient adoption and affect the overall growth forecast.

Opportunities2 items

Emerging markets in Asia Pacific and Latin America, offering untapped opportunities for Captopril Tablets manufacturers to expand their presence and increase the Captopril Tablets market size.

Growing focus on combination therapies, creating opportunities for Captopril Tablets to be used in conjunction with other medications, thereby driving the growth forecast of the market.

Challenges2 items

Fluctuations in raw material prices and supply chain disruptions, affecting the production costs and profitability of Captopril Tablets manufacturers, which may impact the Captopril Tablets market size.

Increasing generic competition and pricing pressure, forcing manufacturers to adopt strategies that balance profitability with affordability, influencing the growth forecast of the market.

Market Segmentation

Loading chart…

The Application segment of the Captopril Tablets market refers to the various uses of Captopril Tablets in treating different medical conditions. This segment is crucial in understanding the Captopril Tablets segmentation and its contribution to the overall market size. The application segment includes subtypes such as hypertension treatment, heart failure treatment, and diabetic nephropathy treatment, among others.

The Types segment of the Captopril Tablets market encompasses the different forms and strengths of Captopril Tablets available in the market. This segment is vital in analyzing the market taxonomy of Captopril Tablets and its impact on the overall market size. The types segment includes subtypes such as 12.5mg, 25mg, 50mg, and 100mg tablets, among others.

Captopril Tablets Segmentation Breakdown7 items

Application

Hypertension

Acute Congestive Heart Failure

Chronic Congestive Heart Failure

Types

Specification 25mg

Specification 12.5mg

Regional Insights

Loading chart…

The Captopril Tablets market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and the fastest-growing region, driven by increasing adoption of Captopril Tablets in the treatment of hypertension and heart failure. Key drivers for Asia Pacific include government policies supporting the development of the pharmaceutical industry, significant investments in healthcare infrastructure, and a large patient population with unmet medical needs.

In North America, key drivers include a mature ecosystem with a well-established healthcare system, high demographics awareness of cardiovascular diseases, and ongoing investments in research and development. Europe is driven by a favorable regulatory environment, a strong infrastructure for pharmaceutical manufacturing, and a high level of adoption of Captopril Tablets in the treatment of cardiovascular diseases. Latin America and Middle East & Africa are expected to experience moderate regional forecast growth, driven by increasing adoption of Captopril Tablets and improving infrastructure.

Competitive Landscape

The Captopril Tablets market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Captopril Tablets competitive landscape is driven by companies seeking to differentiate themselves through strategic positioning, partnerships, and product portfolio management. Key competitive levers include pricing strategies, distribution networks, and innovation in product formulations.

Companies in the Captopril Tablets market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To address these challenges, companies focus on strategic initiatives such as regional expansion, vertical integration, and innovation pipelines.

Wockhardt: regional expansion

Tecoland: premium pricing

Farmhispania: OEM tie-ups

Azelis Deutschland Pharma: local manufacturing

Kerui Pharmaceutical: innovation pipeline

Humanwell Pharmaceutical: vertical integration

Key Captopril Tablets Companies13 items

Wockhardt

Tecoland

Farmhispania

Azelis Deutschland Pharma

Kerui Pharmaceutical

Humanwell Pharmaceutical

Hengcheng Pharmaceutical

Hengwei Pharmaceutical

Zhongfu Pharmaceutical

Likang Pharmaceutical

Changjiang Pharmaceutical

Baiyunshan Pharmaceutical

Huaxin Pharmaceutical

Market Ecosystem

The Captopril Tablets ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream channels and end users. This value chain analysis reveals how value is created and captured across the ecosystem, from the development and manufacturing of Captopril Tablets to their distribution and consumption. The ecosystem can be broadly divided into three segments: upstream, midstream, and downstream, with each segment playing a distinct role in the creation and delivery of Captopril Tablets.

Raw material/component suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing Captopril Tablets

Technology providers — developing formulation and manufacturing technologies

Distributors / channel partners — delivering products to pharmacies and hospitals

Service providers / after-sales — offering patient support and education services

End users / buyers — prescribing and consuming Captopril Tablets

Regulators/standards bodies — setting quality and safety standards

The flow of value in the Captopril Tablets ecosystem is influenced by various control points, including regulatory approvals, quality standards, and partnerships between manufacturers and distributors. Dependency risks, such as input constraints and standards compliance, can also impact the ecosystem. Furthermore, switching costs and interoperability requirements may affect the ability of participants to change partners or suppliers. The ecosystem's dynamics can differ by region, with varying regulatory requirements and market conditions influencing the adoption and consumption of Captopril Tablets.

Recent Industry Insights

The Captopril Tablets industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships and mergers & acquisitions have taken place, with major players forming alliances to enhance their market presence and expand their product portfolios. Additionally, several product launches have been observed, with a focus on improving the efficacy and safety of Captopril Tablets. Regulatory changes have also been introduced, aiming to ensure stricter quality control and adherence to good manufacturing practices. Furthermore, there has been a shift in consumer trends, with an increasing preference for generic and affordable medications, driving the demand for Captopril Tablets.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view of the Captopril Tablets market outlook. The market attractiveness is moderate, driven by the growing prevalence of hypertension and heart failure. Competitive intensity is high, with several major pharmaceutical companies operating in the market. The long-term outlook is positive, with increasing demand for effective and affordable treatment options. The innovation landscape is evolving, with a focus on sustained-release formulations and combination therapies. Demand-supply balance is stable, with key players maintaining a steady supply of Captopril Tablets. However, key risk factors include regulatory changes and generic competition, which may impact market growth.

12 items

1. Executive Summary

2. Captopril Tablets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Captopril Tablets Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Captopril Tablets Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Captopril Tablets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Captopril Tablets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Captopril Tablets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Captopril Tablets Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Captopril Tablets Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Captopril Tablets Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Captopril Tablets Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Captopril Tablets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Captopril Tablets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Captopril Tablets Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Captopril Tablets Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Captopril Tablets Market Competition by Key Manufacturers

9.1. Global Captopril Tablets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Captopril Tablets: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Wockhardt

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Tecoland

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Farmhispania

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Azelis Deutschland Pharma

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Kerui Pharmaceutical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Humanwell Pharmaceutical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Hengcheng Pharmaceutical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Hengwei Pharmaceutical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Zhongfu Pharmaceutical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Likang Pharmaceutical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Changjiang Pharmaceutical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Baiyunshan Pharmaceutical

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Huaxin Pharmaceutical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Captopril Tablets Market

Figure 4: Global Captopril Tablets Market: Drivers

Figure 5: Global Captopril Tablets Market: Challenges

Figure 6: Global Captopril Tablets Market: Trends

Figure 7: Global Captopril Tablets Market: Opportunity

Figure 8: Global Captopril Tablets Market: Restraint

Figure 9: Global Captopril Tablets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Captopril Tablets Market Value (USD Million) By Region

Figure 19: Global Captopril Tablets Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Captopril Tablets Market Value (USD Million) By Region

Figure 27: Global Captopril Tablets Market Share (%) By: Regions (2032)

Figure 28: Global Captopril Tablets Market Volume (K) By Region

Figure 29: Global Captopril Tablets Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Captopril Tablets Market Value (USD Million) By Region

Figure 37: Global Captopril Tablets Market Share (%) By: Regions (2032)

Figure 38: Global Captopril Tablets Market Volume (K) By Region

Figure 39: Global Captopril Tablets Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Captopril Tablets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Captopril Tablets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Captopril Tablets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Captopril Tablets Market Value (USD Million) By Region

Table 14: Global Captopril Tablets Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Captopril Tablets Market Volume (K) By Region

Table 31: Global Captopril Tablets Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Captopril Tablets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Captopril Tablets Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Captopril Tablets Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Wockhardt Basic Information And Sales Area

Table 52: Wockhardt. Products Portfolio

Table 53: Tecoland Basic Information And Sales Area

Table 54: Tecoland. Products Portfolio

Table 55: Farmhispania Basic Information And Sales Area

Table 56: Farmhispania. Products Portfolio

Table 57: Azelis Deutschland Pharma Basic Information And Sales Area

Table 58: Azelis Deutschland Pharma. Products Portfolio

Table 59: Kerui Pharmaceutical Basic Information And Sales Area

Table 60: Kerui Pharmaceutical. Products Portfolio

Table 61: Humanwell Pharmaceutical Basic Information And Sales Area

Table 62: Humanwell Pharmaceutical. Products Portfolio

Table 63: Hengcheng Pharmaceutical Basic Information And Sales Area

Table 64: Hengcheng Pharmaceutical. Products Portfolio

Table 65: Hengwei Pharmaceutical Basic Information And Sales Area

Table 66: Hengwei Pharmaceutical. Products Portfolio

Table 67: Zhongfu Pharmaceutical Basic Information And Sales Area

Table 68: Zhongfu Pharmaceutical. Products Portfolio

Table 69: Likang Pharmaceutical Basic Information And Sales Area

Table 70: Likang Pharmaceutical. Products Portfolio

Table 71: Changjiang Pharmaceutical Basic Information And Sales Area

Table 72: Changjiang Pharmaceutical. Products Portfolio

Table 73: Baiyunshan Pharmaceutical Basic Information And Sales Area

Table 74: Baiyunshan Pharmaceutical. Products Portfolio

Table 75: Huaxin Pharmaceutical Basic Information And Sales Area

Table 76: Huaxin Pharmaceutical. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Captopril Tablets Market Value (USD Million) By Region

Table 86: Global Captopril Tablets Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Captopril Tablets Market Volume (K) By Region

Table 103: Global Captopril Tablets Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Captopril Tablets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 million
Revenue forecast in 2033	7.20 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Wockhardt; Tecoland; Farmhispania; Azelis Deutschland Pharma; Kerui Pharmaceutical; Humanwell Pharmaceutical; Hengcheng Pharmaceutical; Hengwei Pharmaceutical; Zhongfu Pharmaceutical; Likang Pharmaceutical; Changjiang Pharmaceutical; Baiyunshan Pharmaceutical; Huaxin Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options